# Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.

> **NCT04534491** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 855 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Oxybutynin (Oxytrol, BAY839380)

## Key facts

- **NCT ID:** NCT04534491
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-25
- **Primary completion:** 2011-06-22
- **Final completion:** 2011-06-22
- **Target enrollment:** 855 (ACTUAL)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04534491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04534491, "Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04534491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*